Mail & Guardian
Mail & Guardian
astrazenecalatest news & developments
Has Africa taken its foot off the pedal in the race to secure enough Covid-19 vaccines for all?

Africa needs a billion Covid vaccines, but supply is slowing down

Data collected by Unicef shows an alarming drop-off in shipments arriving in the continent since the start of 2022

UK eyes up Covid-19 vaccine donations to slash £140m of foreign aid

The UK is set to count its excess Covid-19 vaccines as part of its aid budget, taking money away from other projects

Video

How your body can protect you from getting sick with Omicron

Omicron’s many mutations allow it to duck our body’s natural defence, but the immune system has a some tricks to prevent you from getting severely ill

How South Africa’s ivermectin use slips through the cracks

There is less demand for ivermectin when South Africa is between Covid-19 waves. But nobody is tracking how many people may be using the animal formulation

If ivermectin had dramatic results in combating Covid-19, it should perform well in any well-conducted, unbiased scientific study, but this is not the case. (Delwyn Verasamy/M&G)

Advocates for ivermectin use severely flawed data

If ivermectin had dramatic results in combating Covid-19, it should perform well in any well-conducted, unbiased scientific study, but this is not the case

There is limited data on the Delta variant in SA, but vaccines remain effective

The Covid-19 J&J and Pfizer vaccines remain effective in protecting against severe sickness and hospitalisation

Level 4 for all to avoid a Gauteng situation in other provinces

The national coronavirus command council explained why additional restrictions were placed on the entire country

The US and South African medicines regulators have faced legal challenges regarding information used to review and approve Pfizer’s Covid-19 vaccine. (Guillem Sartorio/Bloomberg via Getty Images)

Rise of the variants: What you need to know about the Delta variant in SA

SA’s lockdown regulations are tightening to better curb the spread of Covid-19, amid concerns that the Delta variant could drive a surge of infections

Covid-19 patients arrive to the Wakefield Campus of the Montefiore Medical Center on April 06, 2020 in the Bronx borough of New York City. A specialised bus known as a Medical Evacuation Transport Unit (METU), carries patients on stretchers and benches. The patient transfers are designed to help overwhelmed hospitals even out caseloads in Westchester County and New York City at the epicentre of the US coronavirus pandemic.  (Photo by John Moore/Getty Images)

Three for three: Understanding the Covid-19 variants circulating during South Africa’s third wave

Which variants have been detected in SA and how do they differ? Each form of the virus behaves slightly differently and could affect what the pandemic looks like. We break it down.

Targeting the vulnerable: A healthcare worker rests in the hall where people 60 years and old are getting vaccinated with Pfizer vaccines, at Bertha Gxowa Hospital in Germiston. The developing world won’t reach herd immunity any time soon. (Photo: Michele Spatari/AFP)
Video

South Africa’s not reaching herd immunity. Our new goal is containment

South Africa’s stop-start roll-out is not the only reason herd immunity is unrealistic for 2021. A constrained vaccine supply and new variants also play a role

Video

Your guide to side effects: What you can expect after a Covid-19 jab

Soon, South Africa will start with its mass vaccine roll-out. We take a look at what to expect when you get vaccinated.

How South Africa’s Covid vaccine injury fund will work

In the rare event that you experience a severe side-effect as a result of Covid-19 vaccines, this fund will pay you out

The priority for Africa is to achieve herd immunity for Covid-19, the head of the Africa Centres for Disease Control and Prevention (Africa CDC) said at a weekly briefing on Thursday.
 ( Photo by Vincent Kalut / Photonews via Getty Images)

Pfizer backs down over ‘unreasonable’ terms in South Africa vaccine deal

Government, according to Mkhize, is “relieved” as Pfizer eventually conceded and removed the “problematic term”

Paddy Harper’s on the Rastazenica vaccine

Thursday. It’s Day 385 of the Covid-19 lockdown. Like most of my fellow South Africans, I’m wondering when, if ever, it will be my turn to get vaccinated. There’s no real answer…

Top vaccinologist defends government’s Covid-19 vaccine rollout

A group of scientists has criticised the decision to sell SA’s AstraZeneca vaccine and says herd immunity mean vaccines will play a lesser role

Mkhize says SA will sign for 20-million more vaccine doses within two days

The government’s vaccine of choice will be Johnson & Johnson for the moment, the minister tells MPs

Blood-clot fears delay AstraZeneca vaccine roll-out

More than a dozen countries have suspended using the company’s Covid-19 vaccine, because of concerns about possible side effects.

We’re restoring the nation’s health, Ramaphosa says after Covid jab

About 80 000 doses of the Johnson & Johnson vaccine have been sent to about 50 sites for health workers to be vaccinated

Health Minister Dr Zweli Mkhize. (Photo Delwyn Verasamy/M&G)

How SA wants to sell the AstraZeneca vaccine for half the price and what the loss could be

Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap

South Africa is offering its AstraZeneca vaccines to fellow African countries: Mkhize

Reselling the jabs will prevent money being wasted on a vaccine that is not particularly efficacious on the variant that is dominant in South Africa